iShares MSCI Singapore ETF vs InMode Ltd — how do they compare? iShares MSCI Singapore ETF trades at $31.6 (market cap $1.49B), while InMode Ltd trades at $14.21 (market cap $809.93M). The key difference: iShares MSCI Singapore ETF is the larger of the two by market cap, and iShares MSCI Singapore ETF is trading nearer its 52-week high, InMode Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI Singapore ETF for 45 Days and InMode Ltd for 28 Days on average.
| EWS | INMD | |
|---|---|---|
Market Cap | $1.49B | $809.93M |
Volume | 2,142,305 | 365,490 |
Sector | Broad Market / Factor | Health |
52-Week High | $34.57 | $16.62 |
52-Week Low | $26.71 | $12.76 |
Typical Hold Time | 45 Days | 28 Days |
Enterprise Value | — | $313.27M |
Signals from Pluang's Aura AI — not financial advice
EWS (iShares MSCI Singapore ETF) trades at $31.60, down 2.71% with bearish technical signals from moving averages and oscillators. The ETF recently hit 52-week highs amid Singapore's strong economic growth and AI momentum, attracting institutional interest including Amundi's 4.8% position increase. Key support sits at $31 with resistance at $32.
Outlook remains mixed with technical weakness offset by positive fundamental drivers. Investment opportunity lies in Singapore's economic resilience and AI-driven growth, though stretched valuations and bearish momentum present near-term risks. The ETF offers exposure to Asia's outperformance versus S&P 500 but faces volatility from regional economic sensitivity.
INMD trades at $14.08, up 0.5% with mixed technical signals showing bearish moving averages but neutral oscillators. The company maintains strong fundamentals with a P/E of 11.63, gross margins of 76.52%, and consistent revenue around $370M. Recent news includes product innovation with Morpheus8 Cool launch and an unsolicited acquisition offer from Steel Partners at $16.75 per share in July 2026.
Outlook remains cautious with analyst consensus divided (45% Buy, 55% Hold) amid cyclical softness. Investment opportunity lies in potential acquisition premium and international growth, while risks include US sales decline and management capital allocation concerns. The stock faces near-term resistance at $14 with support at the same level.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
EWS tracks the MSCI Singapore 25/50 Index, providing targeted exposure to large and mid-cap companies in Singapore. It is heavily weighted toward the financial, industrial, and real estate sectors, serving as a liquid tool for accessing Singapore's stable, dividend-oriented developed economy.
Read more on EWS →InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.
Read more on INMD →